熱門資訊> 正文

LIXTE Biotechnology重新获得纳斯达克合规

2025-07-16 20:34

LIXTE Biotechnology (NASDAQ:LIXT) announced on Wednesday it has received a Nasdaq letter, stating that the company has regained compliance with Nasdaq’s Listing Rule, requiring a minimum equity requirement of $2.5 million for continued listing.
Shares of LIXT slipped over 17% to $3.0649 during premarket trading.
Source: Press Release

More on Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology announces $5M equity financing; shares down
Financial information for Lixte Biotechnology Holdings, Inc.

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。